
PB2185: MINIMAL RESIDUAL DISEASE AND THE NUMBER OF CD34+ CELLS CIRCULATING IN THE PERIPHERAL BLOOD OF MULTIPLE MYELOMA PATIENTS ON THE DAY OF THE FIRST SESSION OF LEUKOCYTAPHERESIS DURING AUTOGRAFT HARVESTING
Author(s) -
Kostroma I.,
Chubukina Z.,
Sidorova Z.,
Sabitova R.,
Glazanova T.,
Gritsaev S.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000851568.07499.13
Subject(s) - plerixafor , medicine , multiple myeloma , minimal residual disease , mobilization , cd34 , cyclophosphamide , leukapheresis , regimen , surgery , haematopoiesis , bone marrow , granulocyte colony stimulating factor , oncology , stem cell , gastroenterology , chemotherapy , cxcr4 , biology , genetics , chemokine , receptor , archaeology , history